How much semaglutide, tirzepatide or liraglutide is still in your system, how long until it is effectively cleared, and how long a dose change takes to fully land.
These are population averages, not a clearance test. Half-life varies between people with kidney function, body weight and other factors. Use this to understand the shape of the curve and to frame a question, never to decide when it is safe to have a procedure, conceive, or start another medication. Those are decisions for the clinician who knows your history.
Optional. Used to show the estimated amount still circulating.
Pharmacology treats a drug as functionally cleared after about five half-lives, when roughly 97% has been eliminated. That is a convention rather than a hard line, and it says nothing about when the effects stop — appetite and food noise often return well before the last molecule does.
| Medication | Half-life | In days | ~97% cleared | Dosing |
|---|---|---|---|---|
| Semaglutide (Ozempic, Wegovy, Rybelsus) | 165 hours | 6.9 days | 34 days | once weekly |
| Tirzepatide (Mounjaro, Zepbound) | 120 hours | 5.0 days | 25 days | once weekly |
| Liraglutide (Victoza, Saxenda) | 13 hours | 0.5 days | 3 days | once daily |
Approximate elimination half-lives. Individual clearance varies, particularly with reduced kidney function.
Each row is one half-life after your last dose.
| Time after last dose | Estimated remaining | What that means |
|---|
Five half-lives is the working answer — about 34 days for semaglutide, 25 days for tirzepatide, under three days for liraglutide. This is the version of the question that comes up before surgery, before pregnancy, and before starting a medication that might interact.
Pregnancy planning is the case where the gap between the drugs matters most, and it is specifically a conversation to have with a prescriber well in advance rather than working from a table on a website.
The same maths runs in reverse. A weekly drug reaches steady state after roughly four to five half-lives of consistent dosing, so a semaglutide dose increase is still building for four to five weeks. That is one reason titration steps are set four weeks apart, and one reason judging a new dose after ten days tells you very little.
With a half-life around a week, a semaglutide dose missed by a few days leaves most of the previous dose still circulating. That is why the labels allow a delayed dose within a certain window rather than treating it as a restart. What the label actually says depends on the drug and how late you are — the missed dose calculator gives you that rather than a rule of thumb.
GLPme logs every shot, remembers your titration schedule, warns you before you run out of medication, and shows your weight trend against your goal. Core tracking is free.